Lately, the director has been revealing a more philosophical side, often posting cryptic messages on social media ...

The Koffee With Karan maker is selling 50% to its shares to Serene Productions, which is led by pharmaceutical tycoon Adar Poonawalla, for 1,000 crore ($120M). The binding agreement values Dharma ...

Karan Johar recently made headlines after selling half of Dharma – comprising Dharma Productions and Dharmatic Entertainment – to Adar Poonawalla, the CEO of Serum Institute of India ...

KRRO-110 is designed to co-opt an endogenous enzyme, Adenosine Deaminase Acting on RNA’s (ADAR), to edit the “A” variant on SERPINA1 RNA, repair an amino acid codon, and restore secretion of normal ...

Keay Nakae has given his Buy rating due to a combination of factors surrounding the promising potential of ADAR RNA editing technologies. The ADAR-based therapeutics, as discussed in the recent ...

Adar Poonawalla is acquiring a 50% stake in Karan Johar's Dharma Production and Dharmatic Entertainment for Rs 1,000 crore, valuing the company at Rs 2000 crore, according to a report. Johar ...

Adar Poonawalla, the billionaire CEO of Serum Institute of India, has built a reputation for his luxurious lifestyle and high-profile business ventures. From a fleet of supercars to private jets ...

Adar Poonawalla led Serene Productions has announced that it has entered into a binding agreement to invest Rs 1,000 crore into Karan Johar’s Dharma Productions and Dharmatic Entertainment.

Adar Poonawalla-led Serene Productions on Monday announced that it has entered into a binding agreement to invest Rs 1,000 crore in Karan Johar’s Dharma Productions and Dharmatic Entertainment ...

TheSoul Publishing is taking a majority stake in fintech biz Mediacube, as looks to cement a role in the center of the global creator economy.

The vaccine maker's foray into the film industry is expected to be a boost for the Karan Johar-owned production house, which has seen its earnings decline due to multiple factors. The vaccine ...

Billionaire Adar Poonawalla-led Serum Institute of India has held discussions with global private equity firm TPG to sell 40% stake held by the top vaccine maker in SCHOTT Poonawalla, four people ...